Net shares · 365d
-56.5K
0 buy · 56.5K sell
Net value · 365d
-$10.0M
$0 in · $10.0M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
1
0 buy · 56.5K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
JNJ Grant·A
EVP, WWC. Innovative Medicine
$0
58.8K sh · 2 lots
Own New
-
JNJ Exercise·M
EVP, WWC. Innovative Medicine
$0
32.2K sh · 4 lots
Own New
-
JNJ Other·F
EVP, WWC. Innovative Medicine
$3.8M
15.7K sh · $244.43 avg · 4 lots
Own -7%
-
JNJ Exercise·M
EVP, WWC. Innovative Medicine
$0
32.2K sh · 4 lots
Own +20%
-
JNJ Grant·A
EVP, WWC. Innovative Medicine
$0
27.4K sh
Own New
-
MCD Grant·A
Director
$235.0K
769 sh · $305.63
Own +26%
-
MCD Grant·A
Director
$30.0K
99 sh · $303.89
Own +4%
-
JNJ Exercise·M
EVP, WWC. Innovative Medicine
$5.8M
56.5K sh · $101.87
Own New
-
JNJ Sell·S
EVP, WWC. Innovative Medicine
$10.0M
56.5K sh · $177.81
Own -24%
-
JNJ Exercise·M
EVP, WWC. Innovative Medicine
$5.8M
56.5K sh · $101.87
Own +32%
-
MCD Grant·A
Director
$30.0K
103 sh · $292.17
Own +4%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Feb 15, 2026 | JNJ | Grant A | 58.8K2 lots | $0 |
| Feb 15, 2026 | JNJ | Exercise M | 32.2K4 lots | $0 |
| Feb 15, 2026 | JNJ | Other F | 15.7K4 lots | $3.8M |
| Feb 15, 2026 | JNJ | Exercise M | 32.2K4 lots | $0 |
| Feb 9, 2026 | JNJ | Grant A | 27.4K | $0 |
| Dec 31, 2025 | MCD | Grant A | 769 | $235.0K |
| Sep 30, 2025 | MCD | Grant A | 99 | $30.0K |
| Sep 4, 2025 | JNJ | Exercise M | 56.5K | $5.8M |
| Sep 4, 2025 | JNJ | Sell S | 56.5K | $10.0M |
| Sep 4, 2025 | JNJ | Exercise M | 56.5K | $5.8M |
| Jun 30, 2025 | MCD | Grant A | 103 | $30.0K |
Buy Sell Non-market (grant · exercise · gift)
About Taubert Jennifer L
This profile aggregates every SEC Form 4 insider transaction reported by Taubert Jennifer L across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.